Regional variations in prenatal screening across Australia: Stepping towards a national policy framework

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 46, Issue 5, 2006, Pages 427-432

  O'Leary, Peter ^a,b   Breheny, Nikki ^a   Reid, Gabrielle ^c   Charles, Taryn ^a   Emery, Jon ^c  

^a DEPARTMENT OF HEALTH   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antenatal screening; Down syndrome; Policy

Indexed keywords

ACCREDITATION; ADULT; AUSTRALIA; CLINICAL PRACTICE; DATA ANALYSIS; DIAGNOSTIC TEST; DOWN SYNDROME; FEMALE; FETUS DISEASE; GEOGRAPHIC DISTRIBUTION; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE DISTRIBUTION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; MEDICAL DECISION MAKING; MEDICAL INFORMATION; OUTCOMES RESEARCH; PATIENT EDUCATION; PATIENT SATISFACTION; POSTAL MAIL; PRACTICE GUIDELINE; PRENATAL SCREENING; PRIORITY JOURNAL; PROFESSIONAL STANDARD; REVIEW;

ADULT; AGE DISTRIBUTION; AUSTRALIA; BIOLOGICAL MARKERS; DOWN SYNDROME; FEMALE; GENETIC SCREENING; GENETIC TESTING; HEALTH POLICY; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 33748127084     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2006.00629.x     Document Type: Review

References (21)

1. Chan A, Robertson EF, Haan EA, Ranieri E, Keane RJ. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-91. BJOG 1995; 102: 370-376.
2. O'Leary PC, Bower C, Crowhurst J, Murch A, Goldblatt J. The impact of maternal srum screening for Down syndrome in Western Australia: 1980-94. Aust N Z J Obstet Gynaecol 1996; 36: 385-388.
3. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346.
4. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999; 13: 231-237.
5. O'Leary P, Breheny N, Dickinson JE et al. First trimester combined screening for Down syndrome and other fetal anomalies in Western Australia. Obstet Gynecol 2006; 107: 869-876.
6. National Health and Medical Research Council. When Does Quality Assurance in Health Care Require Independent Ethical Review? Advice to Institutions, Human Research Ethics Committees and Health Care Professionals. 2003. [Accessed May 2006.]Available from http://www.nhmrc.gov.au/publications/_files/e46.pdf
7. Laws PJ, Sullivan EA. Australia's Mothers and Babies 2003. AIHW National Perinatal Statistics Unit. Perinatal Statistics Series no. 16. 2005 [Accessed May 2006.]Available from http://www.npsu.unsw.edu.au/ps16.pdf
8. HGSA-RANZCOG. Joint Recommended 'Best Practice'Guidelines on Antenatal Screening for Down Syndrome and Other Fetal Aneuploidy. 2004. [Accessed May 2006.]Available from http://ranzcog.edu.au/publications/statements/ C-obs4.pdf
9. HGSA-RANZCOG. Joint Recommended 'Best Practice'Guidelines on Antenatal Screening for Down Syndrome and Other Fetal Aneuploidy. 2004. [Accessed May 2006.]Available from http://www.hgsa.com.au/
10. Muggli E, Halliday J. Report on Prenatal Diagnostic Testing in Victoria 2004. Victorian Perinatal Data Collection Unit, Department of Human Services, Victoria, Australia. 2005. [Accessed May 2006.]Available from http://www.health.vic.gov.au/perinatal/downloads/ report_diagnostictest2004.pdf
11. Cocciolone R. South Australian Maternal Serum Antenatal Screening (SAMSAS) Program. First trimester screening NT Provider Progress Report (4). 2005. [Accessed May 2006.]Available from http://www.wch.sa.gov.au/ services/az/divisions/labs/geneticmed/pdfs/nt_progress_report4.pdf
12. Chan A, Scott J, Nguyen A-M, Sage L. Pregnancy Outcome in South Australia. 2003. [Accessed May 2006.]Available from http://www.dh.sa.gov.au/pehs/PDF-files/POU-annual-report03.pdf
13. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: The results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003; 7: 1-88.
14. NHS. UK National Screening Committee. Antenatal Screening -Working Standards Incorporating Those for the National Down Screening Program for England. 2003. [Accessed May 2006.]Available from http://www.screening.nhs.uk/downs/policy.htm
15. Mulvey S, Zachariah R, McIlwaine K, Wallace EM. Do women prefer to have screening tests for Down syndrome that have the lowest screen-positive rate or the highest detection rate? Prenat Diag 2003; 23: 828-832.
16. Crossley JA, Aitken DA, Cameron AD, McBride E, Connor JM. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: A Scottish multicentre study. BJOG 2002; 109: 667-676.
17. Nicolaides KH. First trimester screening for fetal abnormalities. Semin Perinatol. 2005; 29: 190-194.
18. Wapner R, Thom E, Simpson JL et al. First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. First-trimester screening for trisomies 21 and 18. New Engl J Med 2003; 349: 1405-1413.
19. Malone FD, Wald NJ, Canick JA et al. First- and second-trimester evaluation of risk (faster) trial: Principal results of the NICHD multicenter down syndrome screening study. Am J Obstet Gynecol 2003 ; 189 (Suppl. 1): S56.
20. Avgidou K, Papageorghiou A, Bindra R, Spencer K, Nicolaides KH. Prospective first-trimester screening for trisomy 21 in 30 564 pregnancies. Am J Obstet Gynecol 2005; 192: 1760-1767.
21. Hodges RJ, Wallace EM. Testing for Down syndrome in the older woman: A risky business? Aust N Z J Obstet Gynaecol 2005; 45: 486-488.